Skip to main content
SpringerLink
Log in

Intraepitheliale Neoplasien

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 5943 Accesses

Zusammenfassung

Das Kapitel behandelt das breite Spektrum der duktalen intraepithelialen Neoplasien, beginnend mit der flachen epithelialen Atypie, über die atypische Hyperplasie bis hin zum DCIS. Die diagnostischen und differentialdiagnostischen Kriterien werden systematisch in allen Aspekten dargestellt. In gleicher Weise werden die lobulären intraepithelialen Neoplasien besprochen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Abati AD, Kimmel M, Rosen PP (1990) Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 94:371–377

    PubMed  CAS  Google Scholar 

  2. Akhtar M, Robinson C, Ali MA, Godwin JT (1983) Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature. Cancer 51:2245–2254

    Article  PubMed  CAS  Google Scholar 

  3. Allred DC, Clark GM, Molina R et al (1992) Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23:974–979

    Article  PubMed  CAS  Google Scholar 

  4. Allred DC, Mohsin SK, Fuqua SA (2001) Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8:47–61

    Article  PubMed  CAS  Google Scholar 

  5. Amendoeira I, Apostolikas N, Bellocq JP et al (2006) Quality assurance guidelines for pathology. Cytological and histological non-operative procedures. In: Wells CA (ed) European guideslines for quality assurance in breast cancer screening and diagnosis. Office for Official Publications of the European Communities, Luxembourg, pp 221–256

    Google Scholar 

  6. Azzopardi JG (1979) Problems in breast Pathology. WB Saunders, London

    Google Scholar 

  7. Azzopardi JG, Smith OD (1959) Salivary gland tumours and their mucins. J Path Bacteriol 77:131–140

    Article  CAS  Google Scholar 

  8. Badve Sa HR (1998) A long term comparative study of the ability of 5 classifications of ductal carcinoma in situ of breast to predict local recurrence after surgical excision. Hum Pathol 29:915–923

    Article  Google Scholar 

  9. Barsky SH, Siegal GP, Jannotta F, Liotta LA (1983) Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49:140–147

    PubMed  CAS  Google Scholar 

  10. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR (1987) Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751–2760

    Article  PubMed  CAS  Google Scholar 

  11. Battifora H (1975) Intracytoplasmic lumina in breast carcinoma: a helpful histopathologic feature. Arch Pathol 99:614–617

    PubMed  CAS  Google Scholar 

  12. Bellamy CO, McDonald C, Salter DM, Chetty U, Anderson TJ (1993) Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 24:16–23

    Article  PubMed  CAS  Google Scholar 

  13. Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJF, van deVijver MJ, Cornelisse C, van Roy F (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107–6115

    PubMed  CAS  Google Scholar 

  14. Betsill Jr WL, Rosen PP, Lieberman PH, Robbins GF (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239:1863–1867

    Article  PubMed  Google Scholar 

  15. Bijker N, Peterse JL, Duchateau L et al (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 10853(19):2263–2271

    Google Scholar 

  16. Bobrow LG, Happerfield LC, Gregory WM, Millis RR (1995) Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers. J Pathol 176:333–341

    Article  PubMed  CAS  Google Scholar 

  17. Bodian CA, Perzin KH, Lattes R (1996) Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer 78:1024–1034

    Article  PubMed  CAS  Google Scholar 

  18. Boecker W (2006) Preneoplasia of the breast. A new conceptual approach to proliferative breast disease. Saunders Elsevier, München

    Google Scholar 

  19. Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138

    Article  PubMed  Google Scholar 

  20. Bratthauer GL, Tavassoli FA (2004) Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 444:340–344

    Article  PubMed  Google Scholar 

  21. Bussolati G, Cattani MG, Gugliotta P, Patriarca E, Eusebi V (1986) Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue. Ann NY Acad Sci 464:262–274

    Article  PubMed  CAS  Google Scholar 

  22. Cardenosa G, Eklund GW (1991) Benign papillary neoplasms of the breast: mammographic findings. Radiology 181:751–755

    PubMed  CAS  Google Scholar 

  23. Carlo VP, Pliss N, Connolly JL, Schnitt SJ (2003) Can absence of high molecular weight cytokeratin expression be used as a marker of atypia in columnar cell lesions of the breast? Mod Pathol 16:24A

    Google Scholar 

  24. Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB (1994) Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol 1:141–146

    Article  PubMed  CAS  Google Scholar 

  25. Carter D, Orr SL, Merino MJ (1983) Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer 52:14–19

    Article  PubMed  CAS  Google Scholar 

  26. Carter DJ (1977) Intraductal papillary tumors of the breast. a study of 78 cases. Cancer 39:1689–1692

    Article  PubMed  CAS  Google Scholar 

  27. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ (2006) Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 30:1002–1007

    Article  PubMed  Google Scholar 

  28. de Mascarel IM, MacGrogan G, Picot V, Dougazz A, Mathoulin-Pelissier S (2006) Results of a long term follow-up study of 115 patients with flat epithelial atypia. Lab Invest 86:25A

    Google Scholar 

  29. De Potter CR, Foschini MP, Schelfhout AM, Schroeter CA, Eusebi V (1993) Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol 422:375–380

    Article  PubMed  Google Scholar 

  30. Deeley TJ (1965) Secondary deposits in the breast. Br J Cancer 19:738–743

    Article  PubMed  CAS  Google Scholar 

  31. Diaz NM, Palmer JO, McDivitt RW (1991) Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients. Am J Clin Pathol 95:614–622

    PubMed  CAS  Google Scholar 

  32. Done SJ, Arneson NC, Ozcelik H, Redston M, Andrulis IL (1998) mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Res 53(58):785–789

    Google Scholar 

  33. Dontu G, Al Hajj M, Abdallah WM, Clarke MF, Wicha MS (2003) Stem cells in normal breast development and breast cancer. Cell Prolif 36(Suppl 1):59–72

    Article  PubMed  CAS  Google Scholar 

  34. Douglas-Jones AG, Gupta SK, Attanoos RL, Morgan JM, Mansel RE (1996) A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma. Histopathology 29:397–409

    Article  PubMed  CAS  Google Scholar 

  35. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151

    Article  PubMed  CAS  Google Scholar 

  36. Dupont WD, Parl FF, Hartmann WH et al (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia [see comments]. Cancer 71:1258–1265

    Article  PubMed  CAS  Google Scholar 

  37. Eusebi V, Collina G, Bussolati G (1989) Carcinoma in situ in sclerosing adenosis of the breast: an immunocytochemical study. Semin Diagn Pathol 6:146–152

    PubMed  CAS  Google Scholar 

  38. Eusebi V, Feudale E, Foschini MP et al (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223–235

    PubMed  CAS  Google Scholar 

  39. Eusebi V, Millis RR, Cattani MG, Bussolati G, Azzopardi JG (1986) Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol 123:532–541

    PubMed  CAS  Google Scholar 

  40. Eusebi V (2000) Lipid-rich carcinoma. In: WHO (ed) Tumours of the breast and female genital organs, chapter 1: tumours of the breast. WHO, Geneva, pp 47–48

    Google Scholar 

  41. Feakins RM, Wells CA, Young KA, Sheaff MT (2000) Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. Hum Pathol 31:1214–1222

    Article  PubMed  CAS  Google Scholar 

  42. Fisher CJ, Millis RR (1992) A mucocoele-like tumour of the breast associated with both atypical ductal hyperplasia and mucoid carcinoma. Histopathology 21:69–71

    Article  PubMed  CAS  Google Scholar 

  43. Fisher ER (1997) Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin 47:52–64

    Article  PubMed  CAS  Google Scholar 

  44. Fisher ER, Brown R (1985) Intraductal signet ring carcinoma. A hitherto undescribed form of intraductal carcinoma of the breast. Cancer 55:2533–2537

    Article  PubMed  CAS  Google Scholar 

  45. Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N (1996) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 78:1403–1416

    Article  PubMed  CAS  Google Scholar 

  46. Foschini MP, Marucci G, Eusebi V (2002) Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch 440:536–542

    Article  PubMed  CAS  Google Scholar 

  47. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ (1998) Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22:1521–1527

    Article  PubMed  CAS  Google Scholar 

  48. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ (2000) Immunophenotype of columnar alteration with prominent apical snouts and secretions (CAPSS). Lab Invest 80:21A

    Google Scholar 

  49. Frykberg ER (1999) Lobular carcinoma in situ of the breast. Breast J 5:296–303

    Article  PubMed  Google Scholar 

  50. Frykberg ER, Santiago F, Betsill Jr WL, O'Brien PH (1987) Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 164:285–301

    PubMed  CAS  Google Scholar 

  51. Fukunaga M, Ushigome S (1998) Small cell (oat cell) carcinoma of the breast. Pathol Int 48:744–748

    Article  PubMed  CAS  Google Scholar 

  52. Goldstein NS, O'Malley BA (1997) Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol 107:561–566

    PubMed  CAS  Google Scholar 

  53. Gottlieb C, Raju U, Greenwald KA (1990) Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol 3:135–140

    PubMed  CAS  Google Scholar 

  54. Greene FI, Page DL, Fleming ID et al (2002) AJCC Cancer Staging Manual, 6th edn. Springer, New York

    Google Scholar 

  55. Guerry P, Erlandson RA, Rosen PP (1988) Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients. Cancer 61:1611–1620

    Article  PubMed  CAS  Google Scholar 

  56. Haagensen CD, Lane N, Lattes R (1972) Neoplastic proliferation of the epithelium of the mammary lobules: adenosis, lobular neoplasia, and small cell carcinoma. Surg Clin North Am 52:497–524

    PubMed  CAS  Google Scholar 

  57. Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769

    Article  PubMed  CAS  Google Scholar 

  58. Hartman AW, Magrish P (1955) Carcinoma of breast in children. Ann Surg 141:792–797

    PubMed  CAS  Google Scholar 

  59. Hijazi YM, Weiss MA (1989) Use of anti-actin and S-100 protein antibodies in differentiating benign and malignant sclerosing breast lesions. Surg Pathol 2:125–135

    Google Scholar 

  60. Hill CB, Yeh IT (2005) Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 123:36–44

    Article  PubMed  Google Scholar 

  61. Ho BC, Tan PH (2005) Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology 37:105–111

    Article  PubMed  Google Scholar 

  62. Hoda SA, Gopalan A (2003) Mammary calcifications of the ossifying type. Breast J 9:129–130

    Article  PubMed  Google Scholar 

  63. Holland R, Hendriks JH (1994) Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11:181–192

    PubMed  CAS  Google Scholar 

  64. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335:519–522

    Article  PubMed  CAS  Google Scholar 

  65. Jensen RA, Page DL (1988) Cystic hypersecretory carcinoma: what's in a name? [letter]. Arch Pathol Lab Med 112:1179–1150

    PubMed  CAS  Google Scholar 

  66. Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977–1983

    Article  PubMed  CAS  Google Scholar 

  67. Klauber-DeMore N, Tan LK, Liberman L et al (2000) Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7:636–642

    Article  PubMed  CAS  Google Scholar 

  68. Kulka J, Davies JD (1993) Mucocoele-like tumours: more associations and possibly ductal carcinoma in situ? Histopathology 22:511–512

    Article  PubMed  CAS  Google Scholar 

  69. Lagios MD, Silverstein MJ (1997) Microinvasion in ductal carcinoma in situ. In: Ductal carcinoma in situ of the breast. Williams and Wilkins, Baltimore, pp 241–246

    Google Scholar 

  70. Lagios MD, Westdahl PR, Margolin FR, Rose MR (1982) Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309–1314

    Article  PubMed  CAS  Google Scholar 

  71. Leal C, Henrique R, Monteiro P et al (2001) Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol 32:487–493

    Article  PubMed  CAS  Google Scholar 

  72. Lefkowitz M, Lefkowitz W, Wargotz ES (1994) Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol 25:802–809

    Article  PubMed  CAS  Google Scholar 

  73. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58:4721–4727

    PubMed  CAS  Google Scholar 

  74. MacGrogan G, Moinfar F, Raju U, Tavassoli FA, Devilee P (2003) Intraductal papillary neoplasms. In: Tumours of the breast and female genital organs. IARC Press, Lyon, pp 76–80

    Google Scholar 

  75. Maluf HM, Koerner FC (1995) Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol 19:1237–1244

    Article  PubMed  CAS  Google Scholar 

  76. Mann GB, Port ER, Rizza C, Tan LK, Borgen PI, Van Zee KJ (1999) Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma. Ann Surg Oncol 6:591–598

    Article  PubMed  CAS  Google Scholar 

  77. Mazoujian G, Pinkus GS, Davis S, Haagensen Jr DE (1983) Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 110:105–112

    PubMed  CAS  Google Scholar 

  78. McDivitt RW, Hutter RV, Foote Jr FW, Stewart FW (1967) situ lobular carcinoma. A prospective follow-up study indicating cumulative patient risks. JAMA 201:82–86

    Article  PubMed  CAS  Google Scholar 

  79. Moinfar F (2007) Low-grade ductal intraepithelial neoplasia (WHO: DIN1b), atypical ductal hyperplasia. In: Essentials of diagnostic breast pathology. Springer, Berlin Heidelberg, pp 74–76

    Google Scholar 

  80. Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Cancer 88:2072–2081

    Article  PubMed  CAS  Google Scholar 

  81. Moll R, Mitze M, Frixen UH, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731–1742

    PubMed  CAS  Google Scholar 

  82. Mulligan AM, O'Malley FP (2007) Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol 15:143–147

    Article  PubMed  Google Scholar 

  83. Naidu R, Yadav M, Nair S, Kutty MK (1998) Expression of c-erbB3 protein in primary breast carcinomas. Br J Cancer 78:1385–1390

    Article  PubMed  CAS  Google Scholar 

  84. Nassar H, Qureshi H, Volkanadsay N, Visscher D (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30:501–507

    Article  PubMed  Google Scholar 

  85. O'Malley FP, Bane AL (2004) The spectrum of apocrine lesions of the breast. Adv Anat Pathol 11:1–9

    Article  PubMed  Google Scholar 

  86. O'Malley FP, Page DL, Nelson EH, Dupont WD (1994) Ductal carcinoma in situ of the breast with apocrine cytology. Definition of a borderline category. Hum Pathol 25:164–168

    Article  PubMed  Google Scholar 

  87. Oberman HA, Markey BA (1991) Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol 4:31–35

    PubMed  CAS  Google Scholar 

  88. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W (2000) Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37:232–240

    Article  PubMed  CAS  Google Scholar 

  89. Oyama T, Iijima K, Takei H, Horiguchi J, Iino Y, Nakajima T, Koerner F (2000) Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer 7:326–331

    Article  PubMed  CAS  Google Scholar 

  90. Oyama T, Maluf H, Koerner F (1999) Atypical cystic lobules: an early stage in the formation of low-grade ductal carcinoma in situ. Virchows Arch 435:413–421

    Article  PubMed  CAS  Google Scholar 

  91. Page DL, Anderson TJ, Rogers LW, Page DL, Anderson TJ (1988) Epithelial hyperplasia. In: Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 120–156

    Google Scholar 

  92. Page DL, Dupont WD (1991) Proliferative breast disease: diagnosis and implications. Science 253:915–916

    PubMed  CAS  Google Scholar 

  93. Page DL, Dupont WD, Jensen RA (1996) Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 5:29–32

    PubMed  CAS  Google Scholar 

  94. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197–1200

    Article  PubMed  CAS  Google Scholar 

  95. Page DL, Dupont WD, Rogers LW, Rados AM (1985) Atypical Hyperplastic Lesions of the Female Breast. A Long-Term Follow-Up Study. Cancer 55:2698–2708

    Article  PubMed  CAS  Google Scholar 

  96. Page DL, Kasami M, Jensen RA (1996) Hypersecretory hyperplasia with atypia in breast biopsies. What is the proper level of clinical concern? Pathol Case Rev 1:36–40

    Article  Google Scholar 

  97. Page DL, Kidd Jr TE, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239

    Article  PubMed  CAS  Google Scholar 

  98. Page DL, Rogers LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Human Pathology 23:1095–1097

    Article  PubMed  CAS  Google Scholar 

  99. Palmer JO, Ghiselli RW, McDivitt RW (1990) Immunohistochemistry in the differential diagnosis of breast diseases. Pathol Annu 25 Pt 2:287–315

    Google Scholar 

  100. Papotti M, Gherardi G, Eusebi V, Pagani A, Bussolati G (1992) Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases. Virchows Arch A Pathol Anat Histopathol 420:103–108

    Article  PubMed  CAS  Google Scholar 

  101. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, Feig SA (1989) Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731–741

    Article  PubMed  CAS  Google Scholar 

  102. Penault-Llorca F, Pomel C, Feillel V, Dauplat J, de Latour M (1998) Microinvasive carcinoma of the breast: Is axillary lymph node dissection indicated? Lab Invest 78:25a

    Google Scholar 

  103. Pick PW, Iossifides IA (1984) Occurrence of breast carcinoma within a fibroadenoma. A review. Arch Pathol Lab Med 108:590–594

    PubMed  CAS  Google Scholar 

  104. Pinder SE, Reis-Filho JS (2006) Non operative breast pathology: columnar cell lesions. J Clin Pathol 60:1307–1312

    Article  PubMed  Google Scholar 

  105. Prasad ML, Osborne MP, Giri DD, Hoda SA (2000) Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol 24:422–428

    Article  PubMed  CAS  Google Scholar 

  106. Quinn CM, Ostrowski JL, Harkins L, Rice AJ, Loney DP (1998) Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins. Histopathology 33:531–536

    Article  PubMed  CAS  Google Scholar 

  107. Rabban JT, Koerner FC, Lerwill MF (2006) Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Hum Pathol 37:787–793

    Article  PubMed  CAS  Google Scholar 

  108. Raju GC (1990) The histological and immunohistochemical evidence of squamous metaplasia from the myoepithelial cells in the breast. Histopathology 17:272–275

    Article  PubMed  CAS  Google Scholar 

  109. Raju U, Vertes D (1996) Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study. Hum Pathol 27:1231–1238

    Article  PubMed  CAS  Google Scholar 

  110. Raju U, Zarbo RJ, Kubus J, Schultz DS (1993) The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis. Hum Pathol 24:173–181

    Article  PubMed  CAS  Google Scholar 

  111. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169:245–250

    Article  PubMed  CAS  Google Scholar 

  112. Reis-Filho JS, Lakhani SR (2003) The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 5:313–319

    Article  PubMed  CAS  Google Scholar 

  113. Rimm DL, Sinard JH, Morrow JS (1995) Reduced alpha-catenin and E-cadherin expression in breast cancer. Lab Invest 72:506–512

    PubMed  CAS  Google Scholar 

  114. Ro JY, Sneige N, Sahin AA, Silva EG, del Junco GW, Ayala AG (1991) Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. Arch Pathol Lab Med 115:137–140

    PubMed  CAS  Google Scholar 

  115. Romero L, Klein L, Ye W, Holmes D, Soni R, Silberman H, Lagios MD, Silverstein MJ (2004) Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 188:371–376

    Article  PubMed  Google Scholar 

  116. Rosai J (1991) Borderline epithelial lesions of the breast. Am J Surg Pathol 15:209–221

    Article  PubMed  CAS  Google Scholar 

  117. Rosen PP (1999) Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 23:1561

    Article  PubMed  CAS  Google Scholar 

  118. Rosen PP (2001) Rosen's breast pathology. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  119. Rosen PP (2009) Rosen's breast pathology. Wolters. Kluwer, Lippincott Wiliams & Wilkins, Philadelphie

    Google Scholar 

  120. Rosen PP, Scott M (1984) Cystic hypersecretory duct carcinoma of the breast. Am J Surg Pathol 8:31–41

    Article  PubMed  CAS  Google Scholar 

  121. Rosner D, Lane WW, Penetrante R (1991) Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 67:1498–1503

    Article  PubMed  CAS  Google Scholar 

  122. Sahoo S, Recant WM (2005) Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast. Breast J 11:140–142

    Article  PubMed  Google Scholar 

  123. Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G (2001) Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 14:768–776

    Article  PubMed  CAS  Google Scholar 

  124. Schnitt SJ (2003) The diagnosis and management of pre-invasive breast disease: Flat epithelial atypia – classification, pathologic features and clinical significance. Breast Cancer Res 5:263–268

    Article  PubMed  Google Scholar 

  125. Schnitt SJ, Conolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman RS, Page DL (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 16:1133–1143

    Article  PubMed  CAS  Google Scholar 

  126. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL (1986) Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 121:1303–1307

    Article  PubMed  CAS  Google Scholar 

  127. Seidman JD, Ashton M, Lefkowitz M (1996) Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer 77:2529–2537

    Article  PubMed  CAS  Google Scholar 

  128. Selim AG, Wells CA (1999) Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 52:838–841

    Article  PubMed  CAS  Google Scholar 

  129. Silver SA, Tavassoli FA (1998) Mammary ductal carcinoma in situ with microinvasion. Cancer 82:2382–2390

    Article  PubMed  CAS  Google Scholar 

  130. Silverstein MJ, Gierson ED, Colburn WJ et al (1994) Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 73:2985–2989

    Article  PubMed  CAS  Google Scholar 

  131. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267–2274

    Article  PubMed  CAS  Google Scholar 

  132. Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461

    Article  PubMed  CAS  Google Scholar 

  133. Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157

    Article  PubMed  CAS  Google Scholar 

  134. Silverstein MJ, Silverstein MJ (1997) Ductal carcinoma in situ with microinvasion. In: Ductal carcinoma in situ of the breast. Williams and Wilkins, Baltimore, pp 557–562

    Google Scholar 

  135. NN (1997) Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol 28: 1221–1225

    Google Scholar 

  136. Sloane JP, Amendoeira I, Apostolikas N et al (1998) Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 29:1056–1062

    PubMed  CAS  Google Scholar 

  137. Sloane JP, Ellman R, Anderson TJ et al (1994) Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U.K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer 30A:1414–1419

    Article  PubMed  CAS  Google Scholar 

  138. Sneige N, Lagios MD, Schwarting R et al (1999) Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol 30:257–262

    Article  PubMed  CAS  Google Scholar 

  139. Sobin LH, Witteking CH (2002) Breast tumors in TNM. Wiley-Liss, New York

    Google Scholar 

  140. Solin LJ, Fowble BL, Yeh IT, Kowalyshyn MJ, Schultz DJ, Weiss MC, Goodman RL (1992) Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 23:961–968

    Article  PubMed  CAS  Google Scholar 

  141. Solin LJ, Kurtz J, Fourquet A (1996) Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754–763

    PubMed  CAS  Google Scholar 

  142. Soo MS, Williford ME, Walsh R, Bentley RC, Kornguth PJ (1995) Papillary carcinoma of the breast: imaging findings. AJR Am J Roentgenol 164:321–326

    PubMed  CAS  Google Scholar 

  143. Stratton MR, Collins N, Lakhani SR, Sloane JP (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175:195–201

    Article  PubMed  CAS  Google Scholar 

  144. Tabár L, Dean PB (1985) Circumscribed lesions; calcifications. In: Teaching atlas of mammography. Thieme, Stuttgart New York, p 18

    Google Scholar 

  145. Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140–154

    PubMed  CAS  Google Scholar 

  146. Tavassoli FA (1999) Ductal intraepithelial neoplasia. In: Pathology of the breast. Appleton & Lange, Stanford, Connecticut, pp 260–323

    Google Scholar 

  147. Tavassoli FA, Hoefler H, Rosai J et al. (2003) Intraductal proliferative lesions. In: Tumours of the breast and female genital organs. IARC-Press, Lyon, pp 63–73

    Google Scholar 

  148. Tavassoli FA, Millis RR, Boecker W, Lakhani SR, Tavassoli FA, Devilee P (2003) Lobular neoplasia. In: Tumours of the breast and female genital organs. IARC Press, Lyon, pp 60–62

    Google Scholar 

  149. Tavassoli FA, Norris HJ (1994) Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases. Mod Pathol 7:813–818

    PubMed  CAS  Google Scholar 

  150. Tremblay G, Deschenes J, Alpert L, Quenneville LA (2005) Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J 11:326–332

    Article  PubMed  CAS  Google Scholar 

  151. Tsang WY, Chan JK (1996) Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 20:921–943

    Article  PubMed  CAS  Google Scholar 

  152. Tsuchiya S (1998) Atypical ductal hyperplasia, atypical lobular hyperplasia and interpretation of a new borderline lesion. Jpn J Cancer Res 44:548–555

    Google Scholar 

  153. Tsuda H, Iwaya K, Fukutomi T, Hirohashi S (1993) p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. Jpn J Cancer Res 84:394–401

    Article  PubMed  CAS  Google Scholar 

  154. van de Vijver MJ, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R (1987) Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 7:2019–2023

    PubMed  Google Scholar 

  155. Weaver MG, Abdul-Karim FW, al Kaisi N (1993) Mucinous lesions of the breast. A pathological continuum. Pathol Res Pract 189:873–876

    Article  PubMed  CAS  Google Scholar 

  156. Weidner N (1995) Malignant breast lesions that may mimic benign tumors. Semin Diagn Pathol 12:2–13

    PubMed  CAS  Google Scholar 

  157. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273

    PubMed  CAS  Google Scholar 

  158. Wells WA, Carney PA, Eliassen MS, Grove MR, Tosteson AN (2000) Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes. Am J Surg Pathol 24:651–659

    Article  PubMed  CAS  Google Scholar 

  159. Wilbur DC, Barrows GH (1993) Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study. Mod Pathol 6:114–120

    PubMed  CAS  Google Scholar 

  160. Wong JH, Kopald KH, Morton DL (1990) The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125:1298–1301

    Article  PubMed  CAS  Google Scholar 

  161. Yaziji H, Gown AM, Sneige N (2000) Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol 7:100–109

    Article  PubMed  CAS  Google Scholar 

  162. Youngson BJ, Cranor M, Rosen PP (1994) Epithelial displacement in surgical breast specimens following needling procedures. Am J Surg Pathol 18:896–903

    Article  PubMed  CAS  Google Scholar 

  163. Youngson BJ, Liberman L, Rosen PP (1995) Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. Am J Clin Pathol 103:598–602

    PubMed  CAS  Google Scholar 

  164. Zavotsky J, Hansen N, Brennan MB, Turner RR, Giuliano AE (1999) Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85:2439–2443

    Article  PubMed  CAS  Google Scholar 

  165. Zurrida S, Bartoli C, Galimberti V, Raselli R, Barletta L (1996) Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ. Ann Surg Oncol 3:57–61

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Werner Böcker Prof. em. Dr. med.

    Present address: Referenz- und Konsultationszentrum für Gynäko- und Mammapathologie, Fangdieckstr. 75a, 22547, Hamburg, Deutschland

  2. Thomas Decker Dr.

    Present address: Institut für Pathologie, Dietrich-Bonhoeffer-Klinikum, Salvador-Allende Str.30, 17036, Neubrandenburg-Oststadt, Deutschland

Authors and Affiliations

  1. Gerhard Domagk Institut für Pathologie der Universität Münster, Münster, Deutschland

    Werner Böcker Prof. em. Dr. med.

Authors
  1. Werner Böcker Prof. em. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Decker Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Böcker Prof. em. Dr. med. .

Editor information

Editors and Affiliations

  1. Institut für Pathologie, Konsultationszentrum für Pankreas- und, TU München, Ismaninger Str. 22, München, 81675, Germany

    Günter Klöppel

  2. Inst. Pathologie, Medizinische Hochschule Hannover (MHH), Carl-Neuberg-Str. 1, Hannover, 30623, Germany

    Hans Kreipe

  3. Kliniken der Landeshauptstadt, Institut für Pathologie, Ludwig-Erhard-Straße 100, Wiesbaden, 65199, Germany

    Wolfgang Remmele

  4. Charite - Universitätsmedizin Berlin, Campus Charité Mitte, Institut für Pathologie, Charitéplatz 1, Berlin, 10117, Berlin, Germany

    Manfred Dietel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Böcker, W., Decker, T. (2013). Intraepitheliale Neoplasien. In: Klöppel, G., Kreipe, H., Remmele, W., Dietel, M. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04564-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04564-6_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04563-9

  • Online ISBN: 978-3-642-04564-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation